Business
US Policy Changes Impact Healthcare and Robotics
The Trump administration is ending subsidies for Medicare drug plans, potentially increasing costs for millions of beneficiaries. Simultaneously, the US has banned foreign-made robots, which could disrupt the domestic robotics industry.
Coverage timeline — 2 articles
NPR
Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.
2026-07-29 20:58 UTC
Ars Technica
Government ban on foreign-made robots may hinder instead of help US robotics.
2026-07-29 20:03 UTC